ARCH Venture Fund XIII, L.P.

10% Owner

Latest Insider Transactions

1 transactions (past 365 days)

LYEL
10% Owner
Purchase
$12.5M
488,090 shares @ $25.61
Filed 2026-03-09Trade 2026-03-06
Lyell Immunopharma, Inc.